Literature DB >> 26070936

Tocilizumab in the treatment of a polyostotic variant of fibrous dysplasia of bone.

Hubert de Boysson1, Alison Johnson2, Naceur Hablani3, Walid Hajlaoui3, Christophe Auzary2, Loïk Geffray2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26070936     DOI: 10.1093/rheumatology/kev221

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

Review 1.  Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review.

Authors:  Iris Hartley; Maria Zhadina; Micheal T Collins; Alison M Boyce
Journal:  Calcif Tissue Int       Date:  2019-04-29       Impact factor: 4.333

2.  RANKL Inhibition in Fibrous Dysplasia of Bone: A Preclinical Study in a Mouse Model of the Human Disease.

Authors:  Biagio Palmisano; Emanuela Spica; Cristina Remoli; Rossella Labella; Annamaria Di Filippo; Samantha Donsante; Fabiano Bini; Domenico Raimondo; Franco Marinozzi; Alan Boyde; Pamela Robey; Alessandro Corsi; Mara Riminucci
Journal:  J Bone Miner Res       Date:  2019-08-21       Impact factor: 6.390

Review 3.  Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.

Authors:  Marlous Rotman; Neveen Agnes Therese Hamdy; Natasha M Appelman-Dijkstra
Journal:  Br J Clin Pharmacol       Date:  2018-12-25       Impact factor: 4.335

4.  Comprehensive management of malocclusion in maxillary fibrous dysplasia: A case report.

Authors:  Harneet Kaur; Sujata Mohanty; Gulsheen Kaur Kochhar; Shahid Iqbal; Anjali Verma; Ritasha Bhasin; Anuraj Singh Kochhar
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

Review 5.  Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation.

Authors:  Alison M Boyce; Michael T Collins
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.